Literature DB >> 10636374

Magnetic-resonance-guided percutaneous laser ablation of uterine fibroids.

P Law, W M Gedroyc, L Regan.   

Abstract

Percutaneous laser ablation of uterine fibroids with magnetic resonance thermal monitoring causes shrinkage of treated areas by 37.5% 3 months later. This technique may provide an alternative to open surgery.

Mesh：

Year:  1999        PMID： 10636374     DOI： 10.1016/s0140-6736(99)04958-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


  6 in total

1.  Real-time magnetic resonance imaging to guide pediatric endovascular procedures.

Authors:  A N Raval; R J Lederman
Journal:  Pediatr Cardiol       Date:  2005 May-Jun       Impact factor: 1.655

2.  Magnetic resonance imaging-guided focused ultrasound ablation of uterine fibroids: early clinical experience.

Authors:  Koji Mikami; Takamichi Murakami; Atsuya Okada; Keigo Osuga; Kaname Tomoda; Hironobu Nakamura
Journal:  Radiat Med       Date:  2008-05-29

Review 3.  Image-guided thermal therapy of uterine fibroids.

Authors:  Shu-Huei Shen; Fiona Fennessy; Nathan McDannold; Ferenc Jolesz; Clare Tempany
Journal:  Semin Ultrasound CT MR       Date:  2009-04       Impact factor: 1.875

4.  Midterm outcome of radiofrequency thermal ablation for symptomatic uterine myomas.

Authors:  Fabio Ghezzi; Antonella Cromi; Valentino Bergamini; Stefano Scarperi; Pierfrancesco Bolis; Massimo Franchi
Journal:  Surg Endosc       Date:  2007-05-19       Impact factor: 4.584

Review 5.  Potential of minimally invasive procedures in the treatment of uterine fibroids: a focus on magnetic resonance-guided focused ultrasound therapy.

Authors:  Krisztina Fischer; Nathan J McDannold; Clare M Tempany; Ferenc A Jolesz; Fiona M Fennessy
Journal:  Int J Womens Health       Date:  2015-11-13

6.  Oxytocin Administration in High-Intensity Focused Ultrasound Treatment of Myomata.

Authors:  Tomasz Lozinski; Justyna Filipowska; Piotr Krol; Anna Kubaty; Piotr Wegrzyn
Journal:  Biomed Res Int       Date:  2018-07-02       Impact factor: 3.411
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.